| Lindsay Michael Vainio, OD | |
|
100 W Park Ave, Anaconda, MT 59711-2259 | |
| (406) 563-6471 | |
| (406) 563-7252 |
| Full Name | Lindsay Michael Vainio |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 8 Years |
| Location | 100 W Park Ave, Anaconda, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962852921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2689 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Leonard E. Vainio And David G. Vainio Pc | 2567362551 | 3 |
News Archive
Today, Dutch biomedical big data company GENALICE officially launched its all-in-one appliance for Next-Gen Sequencing (NGS) data processing, the GENALICE VAULT, at the annual conference of the American Society of Human Genetics.
"U.S. legislators are appealing to the United Nations to take a greater role in addressing Haiti's cholera outbreak, now in its third year and which has left thousands dead," Inter Press Service reports. "In a letter addressed to U.S. Permanent Representative to the United Nations Susan Rice, 104 U.S. members of Congress urged Rice to help step up U.N. concern over the outbreak," the news service writes.
Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore.
Pluristem Therapeutics Inc. today announced that the independent DSMB approved the advancement to the intermediate dose level of the company's placenta derived cell therapy, PLX-PAD, in the Phase I clinical trial in Europe for the treatment of critical limb ischemia (CLI), the end stage of peripheral artery disease (PAD).
› Verified 3 days ago
| Provider Name | Leonard E. Vainio & David G. Vainio Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053342006 PECOS PAC ID: 2567362551 Enrollment ID: O20040113000778 |
News Archive
Today, Dutch biomedical big data company GENALICE officially launched its all-in-one appliance for Next-Gen Sequencing (NGS) data processing, the GENALICE VAULT, at the annual conference of the American Society of Human Genetics.
"U.S. legislators are appealing to the United Nations to take a greater role in addressing Haiti's cholera outbreak, now in its third year and which has left thousands dead," Inter Press Service reports. "In a letter addressed to U.S. Permanent Representative to the United Nations Susan Rice, 104 U.S. members of Congress urged Rice to help step up U.N. concern over the outbreak," the news service writes.
Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore.
Pluristem Therapeutics Inc. today announced that the independent DSMB approved the advancement to the intermediate dose level of the company's placenta derived cell therapy, PLX-PAD, in the Phase I clinical trial in Europe for the treatment of critical limb ischemia (CLI), the end stage of peripheral artery disease (PAD).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Michael Vainio, OD 100 W Park Ave, Anaconda, MT 59711-2259 Ph: (406) 563-6471 | Lindsay Michael Vainio, OD 100 W Park Ave, Anaconda, MT 59711-2259 Ph: (406) 563-6471 |
News Archive
Today, Dutch biomedical big data company GENALICE officially launched its all-in-one appliance for Next-Gen Sequencing (NGS) data processing, the GENALICE VAULT, at the annual conference of the American Society of Human Genetics.
"U.S. legislators are appealing to the United Nations to take a greater role in addressing Haiti's cholera outbreak, now in its third year and which has left thousands dead," Inter Press Service reports. "In a letter addressed to U.S. Permanent Representative to the United Nations Susan Rice, 104 U.S. members of Congress urged Rice to help step up U.N. concern over the outbreak," the news service writes.
Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore.
Pluristem Therapeutics Inc. today announced that the independent DSMB approved the advancement to the intermediate dose level of the company's placenta derived cell therapy, PLX-PAD, in the Phase I clinical trial in Europe for the treatment of critical limb ischemia (CLI), the end stage of peripheral artery disease (PAD).
› Verified 3 days ago
American Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 100 W Park Ave, Anaconda, MT 59711 Phone: 406-563-6471 Fax: 406-563-7252 | |
Anaconda Eye Care Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 112 W 3rd St, Anaconda, MT 59711 Phone: 406-563-5141 | |
Thomas E Yochem, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 112 W 3rd St, Anaconda, MT 59711 Phone: 406-563-5141 | |
Dr. David G Vainio, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 W Park Ave, Anaconda, MT 59711 Phone: 406-563-6471 Fax: 406-563-7252 |